Anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 antibody improves airway inflammation in mice with house dust mite induced asthma

Background: Several biologics have been developed and used to treat severe asthma. However, commercialized biologics have limitations in treating T2-low asthma because their main target is the T2 inflammation marker. Therefore, there is an unmet need for treating T2-low severe asthma. Aminoacyl-tRNA...

Full description

Bibliographic Details
Main Authors: Sung-Ryeol Kim, MD, Yun Jung Um, MSc, Sook In Chung, PhD, Kyoung Yong Jeong, PhD, Hye Jung Park, MD, Kyung Hee Park, MD, Jung-Won Park, MD, Sang Gyu Park, PhD, Jae-Hyun Lee, MD
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455124000875